Terminated PHASE3 INTERVENTIONAL 2-arm NCT02266849

Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

Sponsor: Odense University Hospital

Conditions Rectal Cancer Short Bowel Syndrome Ulcerative Colitis

Updated 5 times since 2017 Last updated: Oct 9, 2016 Started: Oct 31, 2014 Primary completion: Aug 31, 2015 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insuficcient recruiting

Other terminated trials from Odense University Hospital

See all terminations from Odense University Hospital

Other Rectal Cancer trials with similar outcome

Browse all Rectal Cancer trials

A PHASE3 clinical study on Rectal Cancer and Short Bowel Syndrome, this trial is terminated or withdrawn. The trial is conducted by Odense University Hospital and has accumulated 5 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Odense University Hospital

Data source: Odense University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Odense, Denmark